AVANIR PHARMACEUTICALS (AVNR)

[Dakota Option]

Slow and Sweet, Nice d-d, With AVP-923 on the cusp of another FDA approval also treating PBA ---even with the 20 million shares @4.40- {for launch}-you just have to believe since AVNR has the only drug approved to treat PBA ----TAKEOVER TARGET. I keep going back to conference call --Many interested partys---even Prospectus says possible partnership with AVP-923-----IMO even if AVNR is bent on doing it all alone on the launch --someone [PHARMA} out there are licking there chops on this one--- All it takes right now is one leak --soon